HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ian W Flinn Selected Research
Ian W Flinn Research Topics
Disease
57
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2023 - 02/2002
39
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2024 - 02/2002
29
Neoplasms (Cancer)
01/2024 - 02/2002
22
Lymphoma (Lymphomas)
11/2023 - 09/2002
20
Neutropenia
10/2023 - 09/2011
18
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2022 - 02/2004
13
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 02/2010
12
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 01/2005
11
Infections
07/2023 - 08/2003
10
Disease Progression
10/2023 - 08/2004
10
Diarrhea
05/2022 - 03/2014
9
B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 04/2007
9
Pneumonia (Pneumonitis)
04/2021 - 03/2014
7
Fatigue
01/2023 - 04/2007
7
Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 06/2013
7
Thrombocytopenia (Thrombopenia)
01/2021 - 03/2007
6
Febrile Neutropenia
05/2022 - 12/2014
6
Leukemia
01/2019 - 02/2002
4
Residual Neoplasm
01/2023 - 01/2019
4
Nausea
12/2018 - 05/2014
4
Exanthema (Rash)
11/2018 - 09/2011
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2021 - 06/2013
3
Hodgkin Disease (Hodgkin's Disease)
01/2021 - 08/2004
3
Multiple Myeloma
01/2021 - 01/2011
3
Colitis
01/2019 - 12/2016
3
Fever (Fevers)
12/2018 - 04/2007
3
Anemia
12/2018 - 05/2014
2
Hemorrhage
07/2023 - 01/2017
2
Lymphocytosis
07/2023 - 03/2013
2
Atrial Fibrillation
07/2023 - 04/2021
2
Hypertension (High Blood Pressure)
07/2023 - 01/2022
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 06/2021
2
Sepsis (Septicemia)
04/2021 - 03/2017
2
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
04/2021 - 03/2017
2
Body Weight (Weight, Body)
01/2020 - 12/2017
2
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2019 - 08/2003
2
Tumor Lysis Syndrome
01/2019 - 12/2014
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 10/2017
2
Vomiting
04/2016 - 05/2014
2
Lymphadenopathy
05/2014 - 03/2013
2
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2007 - 04/2006
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2023
Drug/Important Bio-Agent (IBA)
44
Rituximab (Mabthera)
FDA Link
10/2023 - 02/2002
19
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2021 - 08/2003
18
ibrutinib
IBA
01/2024 - 07/2013
15
Bendamustine Hydrochloride
FDA Link
01/2022 - 05/2014
12
fludarabine
IBA
11/2018 - 02/2002
11
idelalisib
IBA
01/2021 - 03/2013
10
Monoclonal Antibodies
IBA
10/2023 - 02/2002
10
Prednisone (Sone)
FDA Link
Generic
01/2021 - 08/2003
10
Vincristine (Oncovin)
FDA Link
Generic
01/2021 - 08/2003
9
Agammaglobulinaemia Tyrosine Kinase
IBA
07/2023 - 05/2015
9
obinutuzumab
IBA
01/2022 - 01/2019
9
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021 - 08/2003
8
Chlorambucil (Leukeran)
FDA Link
01/2022 - 05/2006
7
ofatumumab
FDA Link
01/2019 - 01/2016
6
Transaminases (Aminotransferases)
IBA
12/2021 - 03/2014
6
ibritumomab tiuxetan (Zevalin)
FDA Link
06/2021 - 02/2002
5
Chimeric Antigen Receptors
IBA
11/2023 - 12/2017
5
axicabtagene ciloleucel
IBA
11/2023 - 12/2017
5
venetoclax
IBA
07/2023 - 01/2019
5
Yttrium
IBA
06/2021 - 02/2002
5
duvelisib
IBA
12/2019 - 01/2018
4
acalabrutinib
IBA
01/2024 - 01/2020
4
zanubrutinib
IBA
01/2024 - 10/2020
4
Proteins (Proteins, Gene)
FDA Link
01/2022 - 04/2003
3
Antibodies
IBA
10/2023 - 08/2003
3
Lenalidomide (CC 5013)
FDA Link
10/2022 - 01/2018
3
Phosphatidylinositols (Phosphatidylinositol)
IBA
12/2021 - 05/2014
3
umbralisib
IBA
12/2021 - 01/2018
3
nilotinib
FDA Link
07/2021 - 09/2011
3
Imatinib Mesylate (Gleevec)
FDA Link
07/2021 - 09/2011
3
Bortezomib (Velcade)
FDA Link
01/2018 - 09/2006
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2018 - 05/2014
3
Interleukin-2 (IL2)
IBA
10/2007 - 12/2005
2
pirtobrutinib
IBA
07/2023 - 01/2021
2
Azacitidine (5 Azacytidine)
FDA Link
01/2023 - 04/2004
2
brexucabtagene autoleucel
IBA
01/2023 - 01/2020
2
3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dione
IBA
05/2022 - 02/2022
2
carfilzomib
IBA
01/2021 - 05/2015
2
Panobinostat
IBA
01/2021 - 05/2015
2
Phosphotransferases (Kinase)
IBA
01/2021 - 05/2014
2
enasidenib
IBA
01/2019 - 10/2017
2
R-CHOP protocol
IBA
01/2019 - 02/2010
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
12/2018 - 05/2014
2
Alanine Transaminase (SGPT)
IBA
01/2018 - 05/2014
2
Alkylating Agents
IBA
01/2017 - 03/2014
2
TRU 016
IBA
01/2015 - 02/2014
2
Immunoglobulins (Immunoglobulin)
IBA
06/2014 - 02/2004
2
lumiliximab
IBA
01/2010 - 08/2007
2
Alemtuzumab (Campath)
FDA Link
01/2005 - 05/2004
2
Complement System Proteins (Complement)
IBA
04/2003 - 02/2002
1
Bispecific Antibodies
IBA
03/2024
Therapy/Procedure
42
Therapeutics
11/2023 - 03/2002
17
Drug Therapy (Chemotherapy)
10/2022 - 02/2002
6
Radioimmunotherapy
06/2021 - 02/2002
4
Stem Cell Transplantation
01/2022 - 03/2002
4
Transplantation
10/2007 - 01/2005
2
Duration of Therapy
07/2023 - 01/2023
2
Immunotherapy
01/2018 - 06/2014